- Title: Subtitle
- Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
- Creators
- Paolo Antonio Ascierto - Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"Bernard FoxWalter UrbaAna Carrizosa Anderson - Harvard UniversityMichael B Atkins - Georgetown UniversityErnest C Borden - University of Wisconsin–MadisonJulie Brahmer - Johns Hopkins UniversityLisa H Butterfield - University of California, San FranciscoAlessandra Cesano - Essa Pharma (United States)Daniel Chen - IGM Biosciences (United States)Tanja de Gruijl - Vrije Universiteit AmsterdamRobert O Dillman - AIVITA Biomedical IncCharles G Drake - Columbia UniversityLeisha A Emens - University of PittsburghThomas F Gajewski - University of ChicagoJames L Gulley - National Institutes of HealthF Stephen Hodi - Dana Farber Cancer Institute, Boston, Massachusetts, USAPatrick Hwu - The University of Texas MD Anderson Cancer CenterDavid Kaufman - Gates FoundationHoward Kaufman - Acumentrics (United States)Michael Lotze - University of PittsburghDouglas G McNeel - University of Wisconsin–MadisonKim Margolin - City Of Hope National Medical CenterFrancesco Marincola - Refuge Biotechnologies (United States)Michael J Mastrangelo - Thomas Jefferson UniversityMarcela V Maus - Harvard UniversityDavid R Parkinson - Essa Pharma (United States)Pedro J Romero - University of LausannePaul M Sondel - University of Wisconsin–MadisonStefani Spranger - Massachusetts Institute of TechnologyMario Sznol - Yale UniversityGeorge J Weiner - University of IowaJon M Wiggington - MacroGenics (United States)Jeffrey S Weber - New York University
- Resource Type
- Editorial
- Publication Details
- Journal for immunotherapy of cancer, Vol.8(1), p.e000878
- DOI
- 10.1136/jitc-2020-000878
- PMID
- 32300051
- PMCID
- PMC7204613
- NLM abbreviation
- J Immunother Cancer
- ISSN
- 2051-1426
- eISSN
- 2051-1426
- Language
- English
- Date published
- 04/16/2020
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Pharmaceutical Sciences and Experimental Therapeutics; Internal Medicine
- Record Identifier
- 9984359952502771
Editorial
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
Journal for immunotherapy of cancer, Vol.8(1), p.e000878
04/16/2020
DOI: 10.1136/jitc-2020-000878
PMCID: PMC7204613
PMID: 32300051
Details
Metrics
13 Record Views